3PSFPP110

Due to market price fluctuations, if you need to purchase or consult the price. You can contact us or emial to us:   sales@allicdata.com

3PSFPP110 is a type of cell-free protein production system, consisting of a cell-free Soluble Protein Extract (SPE) and an appropriate extract enhancer. The main components of SPE are eukaryotic mRNA, ribosomes, amino acids, and all the necessary energy and cofactors needed for protein synthesis. The 3PSFPP110 system is used for in vitro protein synthesis, providing high yields of translated proteins within a few hours, without the need for isolation and culturing of viable cells. It is an important tool in the field of protein expression and analysis, as it significantly reduces the time and cost associated with traditional cell-based protein expression techniques.

The 3PSFPP110 system is typically employed to synthesize soluble and membrane proteins, serve as a protein expression platform, and facilitate the production and screening of protein variants and libraries. It also offers enhanced yields of protein, increased translation efficiencies and the ability to work with challenging proteins. Proteins synthesized in 3PSFPP110 can be used for characterization, crystallography, and biochemical and proteomic analysis, which can help to identify proteins involved in various physiological and pathological processes.

The 3PSFPPP110 system works by providing the cellular machinery with the necessary conditions and components for protein production, such as translation machinery, energy and cofactors, and the mRNA template. The SPE is activated and binds to the mRNA template, initiating translation of the mRNA into a polypeptide chain. The SPE then releases the growing polypeptide chain, which folds into an active tertiary structure as post-translational modifications occur. Finally, the polypeptide is released into the environment as a mature, active protein.

The 3PSFPP110 system is an effective and versatile tool for protein expression and a valuable addition to the repertoire of cell-free expression systems. With its rapid turnover time, low cost, and high yields, it is a viable alternative to existing cell-based protein production methods. It also offers a high degree of scalability, allowing for easy and efficient upscaling of expression volume with minimal impact on protein yield.

The 3PSFPP110 system is applicable in many fields, from pharmaceuticals and biotechnology, to structural biology, endocrinology, and immunology. For pharmaceuticals, the system can be used to produce and test drug candidate compounds for their efficacy, bioavailability, stability, and toxicity. Additionally, it can be used to produce biochemicals for the development of new diagnostic assays and technological applications, such as biosensors and nanotechnology. In biotechnology, the system can provide increased yields of recombinant proteins, antibodies, and synbodies, which can then be used to study diseases. Lastly, in structural biology, the system helps to gain knowledge of protein structure-function relationships, which can lead to better understanding of the mechanisms by which proteins control various biochemical processes.

In conclusion, the 3PSFPP110 system is a powerful and effective tool for protein expression and production. With its high yields and low cost, it is an attractive alternative to traditional cell-based methods, particularly for the production of proteins in industrial and research contexts. It is also applicable in a variety of fields, offering great potential for the development and optimization of therapeutic drugs, biochemicals, and technologies, with far-reaching implications in areas ranging from medicine to industry.

The specific data is subject to PDF, and the above content is for reference